New SEC Form D filing

Accipiter Biosciences Inc., 2026-07-28

A new SEC Form D private-offering notice from Seattle, WA, a $10,492,778 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Accipiter Biosciences Inc. site↗ Verified via SEC Form D

Designs de novo, multifunctional protein therapies for complex diseases like autoimmune disorders and cancer using computational protein design.

Filed 2026-07-28Filed to raise $10,492,778First money in 2026-07-21Raised so far $10,492,778HQ (as filed) Seattle, WASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified accipiterbio.com↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Washington →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source